Results 241 to 250 of about 1,734,152 (292)

Exploratory Pain Profiling With Quantitative Sensory Testing (QST) in Episodic and Chronic Migraine. [PDF]

open access: yesEur J Pain
van Welie RF   +6 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Emerging treatment for chronic migraine and refractory chronic migraine

Expert Opinion on Emerging Drugs, 2012
Chronic migraine (CM), the suffering of 15 or more headache days with at least 8 of these migraine days, afflicts 1.3% - 5.1% of the global population. CM is the most common disorder faced by experts in tertiary headache centers. When resistant to conventional medical treatment and prophylactic medication this condition is known as refractory chronic ...
Giovanna Gentile   +2 more
exaly   +4 more sources

Management of chronic migraine

BMJ, 2022
ABSTRACT Chronic migraine is a neurologic disorder associated with considerable disability, lost productivity, and a profound economic burden worldwide. The past five years have seen a dramatic expansion in new treatments for this often challenging condition, among them calcitonin gene related peptide antagonists and neuromodulatory ...
Alexandra, Hovaguimian, Julie, Roth
openaire   +2 more sources

Chronic migraine

BMJ, 2014
Chronic migraine is a disabling neurologic condition that affects 2% of the general population. Patients with chronic migraine have headaches on at least 15 days a month, with at least eight days a month on which their headaches and associated symptoms meet diagnostic criteria for migraine.
H C, Diener   +4 more
openaire   +4 more sources

Chronic migraine

Revue Neurologique, 2013
The second edition of the International Classification of Headache Disorders revised in 2006 (ICHD-2R) gives a definition which requires 15 or more headache days per month over the past 3months with at least eight headache days per month that meet criteria for migraine without aura or that responds to migraine specific treatment.
  +5 more sources

Chronic Migraine

Neurology India, 2021
Background: Chronic migraine is an under-recognized and under-treated disorder. A greater understanding of the pathophysiology of migraine and transformation to chronic migraine has led to the first targeted treatments for chronic migraine.
Catriona L, Gribbin   +2 more
openaire   +2 more sources

Chronic Infections and Migraine

Headache: The Journal of Head and Face Pain, 2004
Chronic infections and ...
Candelli, Marcello   +3 more
openaire   +3 more sources

OnabotulinumtoxinA for Chronic Migraine

Headache: The Journal of Head and Face Pain, 2012
In 1992, Binder, a facial plastic surgeon in Los Angeles, first noted migraine improvement in a patient he was injecting with onabotulinumtoxinA for wrinkles.At the American Headache Society meeting in 1998, Binder and colleagues presented the first poster on onabotulinumtoxinA treatment in patients with migraine.
Andrew, Blumenfeld, Randolph W, Evans
openaire   +3 more sources

Treatment of Chronic Migraine

Current Pain and Headache Reports, 2010
Chronic migraine is defined in different ways. The most commonly used definition is headache on more than 15 days per month in patients with migraine. Chronic migraine is difficult to treat and requires a multidisciplinary approach. Only two pharmacological treatments have been shown to be effective in placebo-controlled randomized trials: topiramate ...
Diener, Hans Christoph   +2 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy